Literature DB >> 35083493

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience.

Danielle Rogner1, Tilo Biedermann, Felix Lauffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35083493      PMCID： PMC9558320          DOI： 10.2340/actadv.v102.1088

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  15 in total

1.  Visual analogue scale: evaluation of the instrument for the assessment of pruritus.

Authors:  Adam Reich; Monika Heisig; Ngoc Quan Phan; Kenichi Taneda; Kenji Takamori; Satoshi Takeuchi; Masutaka Furue; Christine Blome; Matthias Augustin; Sonja Ständer; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2012-09       Impact factor: 4.437

2.  Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented SCORAD and Three-Item Severity score.

Authors:  Arnold P Oranje
Journal:  Curr Probl Dermatol       Date:  2011-05-12

3.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.

Authors:  J M Hanifin; M Thurston; M Omoto; R Cherill; S J Tofte; M Graeber
Journal:  Exp Dermatol       Date:  2001-02       Impact factor: 3.960

4.  Dermatology Life Quality Index use in skin disease guidelines and registries worldwide.

Authors:  R K Singh; A Y Finlay
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-26       Impact factor: 6.166

5.  Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.

Authors:  A Wollenberg; S Barbarot; T Bieber; S Christen-Zaech; M Deleuran; A Fink-Wagner; U Gieler; G Girolomoni; S Lau; A Muraro; M Czarnecka-Operacz; T Schäfer; P Schmid-Grendelmeier; D Simon; Z Szalai; J C Szepietowski; A Taïeb; A Torrelo; T Werfel; J Ring
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-06       Impact factor: 6.166

Review 6.  Target-oriented therapy: Emerging drugs for atopic dermatitis.

Authors:  Felix Lauffer; Johannes Ring
Journal:  Expert Opin Emerg Drugs       Date:  2016-02-15       Impact factor: 4.191

7.  Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.

Authors:  E L Simpson; J-P Lacour; L Spelman; R Galimberti; L F Eichenfield; R Bissonnette; B A King; J P Thyssen; J I Silverberg; T Bieber; K Kabashima; Y Tsunemi; A Costanzo; E Guttman-Yassky; L A Beck; J M Janes; A M DeLozier; M Gamalo; D R Brinker; T Cardillo; F P Nunes; A S Paller; A Wollenberg; K Reich
Journal:  Br J Dermatol       Date:  2020-03-05       Impact factor: 9.302

8.  Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.

Authors:  K Reich; A M DeLozier; F P Nunes; J P Thyssen; L F Eichenfield; A Wollenberg; J A Ross Terres; S D Watts; Y-F Chen; E L Simpson; J I Silverberg
Journal:  J Dermatolog Treat       Date:  2020-11-22       Impact factor: 3.230

9.  Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.

Authors:  Amy S Paller; Ashish Bansal; Eric L Simpson; Mark Boguniewicz; Andrew Blauvelt; Elaine C Siegfried; Emma Guttman-Yassky; Thomas Hultsch; Zhen Chen; Paola Mina-Osorio; Yufang Lu; Ana B Rossi; Xinyi He; Mohamed Kamal; Neil M H Graham; Gianluca Pirozzi; Marcella Ruddy; Laurent Eckert; Abhijit Gadkari
Journal:  Am J Clin Dermatol       Date:  2020-02       Impact factor: 7.403

10.  Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.

Authors:  Kristian Reich; Kenji Kabashima; Ketty Peris; Jonathan I Silverberg; Lawrence F Eichenfield; Thomas Bieber; Aleksandra Kaszuba; Jill Kolodsick; Fan E Yang; Margaret Gamalo; Dennis R Brinker; Amy M DeLozier; Jonathan M Janes; Fabio P Nunes; Jacob P Thyssen; Eric L Simpson
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282
View more
  1 in total

Review 1.  [Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience].

Authors:  Felix Lauffer; Tilo Biedermann
Journal:  Dermatologie (Heidelb)       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.